These results suggested that kinsenoside prevented the destruction of connective tissues by simultaneously augmenting IL-10 production and reducing IL-1β, TNF-α, and MMP-9 production at inflammatory sites in mice with RA. This evidence concerns the gene TNF and rheumatoid arthritis.